BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21946245)

  • 1. The management of primary central nervous system lymphoma related to AIDS in the HAART era.
    González-Aguilar A; Soto-Hernández JL
    Curr Opin Oncol; 2011 Nov; 23(6):648-53. PubMed ID: 21946245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
    Diamond C; Taylor TH; Aboumrad T; Anton-Culver H
    Cancer; 2006 Jan; 106(1):128-35. PubMed ID: 16329140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole brain radiation alone produces favourable outcomes for AIDS-related primary central nervous system lymphoma in the HAART era.
    Nagai H; Odawara T; Ajisawa A; Tanuma J; Hagiwara S; Watanabe T; Uehira T; Uchiumi H; Yotsumoto M; Miyakawa T; Watanabe A; Kambe T; Konishi M; Saito S; Takahama S; Tateyama M; Okada S
    Eur J Haematol; 2010 Jun; 84(6):499-505. PubMed ID: 20132301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options for central nervous system lymphomas in immunocompetent patients.
    Jahnke K; Thiel E
    Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era.
    Cingolani A; Fratino L; Scoppettuolo G; Antinori A
    J Neurovirol; 2005; 11 Suppl 3():38-44. PubMed ID: 16540454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired immunodeficiency syndrome-related lymphoma: clinical aspects.
    Levine AM
    Semin Oncol; 2000 Aug; 27(4):442-53. PubMed ID: 10950371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management of primary central nervous system lymphoma.
    Schultz CJ; Bovi J
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):666-78. PubMed ID: 20159361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary central nervous system lymphomas.
    Batara JF; Grossman SA
    Curr Opin Neurol; 2003 Dec; 16(6):671-5. PubMed ID: 14624075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS-related primary central nervous system lymphoma.
    Kasamon YL; Ambinder RF
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):665-87, vi-vii. PubMed ID: 16083829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.
    Newell ME; Hoy JF; Cooper SG; DeGraaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI
    Cancer; 2004 Jun; 100(12):2627-36. PubMed ID: 15197806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS-related cancer in the era of highly active antiretroviral therapy (HAART): a model of the interplay of the immune system, virus, and cancer. "On the offensive--the Trojan Horse is being destroyed"--Part B: Malignant lymphoma.
    Cheung TW
    Cancer Invest; 2004; 22(5):787-98. PubMed ID: 15581059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
    Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
    HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART.
    Navarro JT; Vall-Llovera F; Mate JL; Morgades M; Feliu E; Ribera JM
    Haematologica; 2008 Jan; 93(1):149-50. PubMed ID: 18166804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic HIV-non-Hodgkin lymphoma in the era of HAART. Natural history].
    Juzbasic S; Spina M; Vaccher E; Tirelli U
    Recenti Prog Med; 2001 Nov; 92(11):676-89. PubMed ID: 11765662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL).
    Raez LE; Patel P; Feun L; Restrepo A; Raub WA; Cassileth PA
    Crit Rev Oncog; 1998; 9(3-4):199-208. PubMed ID: 10201628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of primary central nervous system lymphoma.
    Deangelis LM
    Oncology (Williston Park); 1995 Jan; 9(1):63-71; discussion 71, 75-6, 78. PubMed ID: 7718442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the management of primary CNS lymphoma.
    Nasir S; DeAngelis LM
    Oncology (Williston Park); 2000 Feb; 14(2):228-34; discussion 237-42, 244. PubMed ID: 10736810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.